Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
BACKGROUND: Antidepressant prescribing is widespread. Nonetheless, response to antidepressants is variable. If it was possible to predict response to medication and thus tailor treatment accordingly, this would not only improve patient outcomes but may also have economic benefits. AIMS: To test the...
Auteurs principaux: | Wiles, N, Mulligan, J, Peters, T, Cowen, P, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Lewis, G |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
par: Thomas, L, et autres
Publié: (2008) -
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
par: O'Donovan Michael, et autres
Publié: (2008-05-01) -
Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
par: Wiles, N, et autres
Publié: (2014) -
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
par: Lewis, G, et autres
Publié: (2011) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
par: Crawford, A, et autres
Publié: (2014)